SLC46A3
Lysosomal proton-coupled steroid conjugate and bile acid symporter SLC46A3
Also known as: DKFZp686A1775, FLJ42613, S46A3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z3Q1
- Gene
- SLC46A3
- Ensembl
- ENSG00000139508
- Chromosome
- 13
- Canonical length
- 461 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane,Actin filaments,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of a transmembrane protein family that transports small molecules across membranes. The encoded protein has been found in lysosomal membranes, where it can transport catabolites from the lysosomes to the cytoplasm. This protein has been shown to be an effective transporter of the cytotoxic drug maytansine, which is used in antibody-based targeting of cancer cells. [provided by RefSeq, Dec 2016]
Canonical amino-acid sequenceUniProt
461 residues, UniProt reviewed canonical sequence.
>Q7Z3Q1|SLC46A3
1 MKILFVEPAI FLSAFAMTLT GPLTTQYVYR RIWEETGNYT FSSDSNISEC EKNKSSPIFA
61 FQEEVQKKVS RFNLQMDISG LIPGLVSTFI LLSISDHYGR KFPMILSSVG ALATSVWLCL
121 LCYFAFPFQL LIASTFIGAF CGNYTTFWGA CFAYIVDQCK EHKQKTIRIA IIDFLLGLVT
181 GLTGLSSGYF IRELGFEWSF LIIAVSLAVN LIYILFFLGD PVKECSSQNV TMSCSEGFKN
241 LFYRTYMLFK NASGKRRFLL CLLLFTVITY FFVVIGIAPI FILYELDSPL CWNEVFIGYG
301 SALGSASFLT SFLGIWLFSY CMEDIHMAFI GIFTTMTGMA MTAFASTTLM MFLARVPFLF
361 TIVPFSVLRS MLSKVVRSTE QGTLFACIAF LETLGGVTAV STFNGIYSAT VAWYPGFTFL
421 LSAGLLLLPA ISLCVVKCTS WNEGSYELLI QEESSEDASD RLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC46A3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 11
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 90 nTPM
Expression across tissuesHPA
Tissue
- liver: 90 nTPM
- small intestine: 72 nTPM
- duodenum: 44 nTPM
- parathyroid gland: 23 nTPM
- gallbladder: 22 nTPM
- colon: 19 nTPM
Single-cell type
- enterocytes: 148 nCPM
- breast lactating cells: 89 nCPM
- sertoli cells: 86 nCPM
- kupffer cells: 81 nCPM
- thyrotrophs: 79 nCPM
- retinal bipolar cells: 71 nCPM
Immune cell
- basophil: 33 nTPM
- non-classical monocyte: 20 nTPM
- intermediate monocyte: 13 nTPM
- myeloid DC: 12 nTPM
- naive CD4 T-cell: 11 nTPM
- plasmacytoid DC: 11 nTPM
Brain region
- choroid plexus: 21 nTPM
- cerebellum: 16 nTPM
- spinal cord: 14 nTPM
- thalamus: 14 nTPM
- pons: 12 nTPM
- midbrain: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.18
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.49
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to 2,3,7,8-tetrachlorodibenzodioxine
- vacuolar transmembrane transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC46A3 as an antibody target. Whether an autoantibody or antibody against SLC46A3 could matter depends on whether native SLC46A3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC46A3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- This protein has been shown to be an effective transporter of the cytotoxic drug maytansine, which is used in antibody-based targeting of cancer cells.
Loading the interactive Seroatlas protein explorer...